These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
211 related articles for article (PubMed ID: 6140616)
61. [Effects of ranitidine, a new histamine H2-receptor antagonist, on histamine- and aspirin-induced gastric ulcers in rats and dogs (author's transl)]. Okabe S; Tabata K; Ohtsuki H Nihon Yakurigaku Zasshi; 1981 Dec; 78(6):549-55. PubMed ID: 6120886 [TBL] [Abstract][Full Text] [Related]
62. [Modern policy of anti-helicobacter therapy of ulcer disease]. Ryss ES Klin Med (Mosk); 1998; 76(10):7-11. PubMed ID: 9865008 [No Abstract] [Full Text] [Related]
63. [Influence of anti-H2-receptors on the surgery of peptic ulcer]. Cavallesco NG; Morsiani E; Lupi L; Dalla Valle GB; Fogli L; Belcastro S; Pampolini M; Pollice S; Santini A Minerva Chir; 1987 Oct; 42(19):1495-7. PubMed ID: 2891086 [No Abstract] [Full Text] [Related]
69. [Histamine 2 receptor antagonists in the treatment of gastric ulcer]. Avella J; Pounder RE; Matos-Villalobos M G E N; 1975; 30(1-2):115-23. PubMed ID: 16809 [TBL] [Abstract][Full Text] [Related]
70. Duodenal ulcer. Who should have long-term maintenance therapy? Zuckerman G Postgrad Med; 1987 Oct; 82(5):52-3, 57-8, 60. PubMed ID: 2890147 [TBL] [Abstract][Full Text] [Related]
71. Current status of maintenance therapy in peptic ulcer disease. The ACG Committee on FDA-Related Matters. Am J Gastroenterol; 1988 Jun; 83(6):607-17. PubMed ID: 2897783 [No Abstract] [Full Text] [Related]
72. Maintenance therapy of duodenal and gastric ulcer with H2-receptor antagonists. Boyd EJ; Penston JG; Wormsley KG Scand J Gastroenterol Suppl; 1990; 178():72-8. PubMed ID: 2277972 [TBL] [Abstract][Full Text] [Related]
73. [Gastrointestinal pathology following orthotopic transplantation of the liver in the pig]. Arias J; Aller MA; Lorente L; Jiménez G; Rodríguez J; Estébanez E; Gómez de Enterría F; Arias L; Durán M; Brandau D Rev Esp Enferm Apar Dig; 1987 Sep; 72(3):193-200. PubMed ID: 2891160 [No Abstract] [Full Text] [Related]
74. [Effects of FRG-8813, a new type histamine H2-receptor antagonist, on various experimental gastric and duodenal lesions in rats]. Yamaura T; Shibata M; Inaba N; Onodera S; Chida Y; Ohnishi H Nihon Yakurigaku Zasshi; 1992 Jun; 99(6):401-10. PubMed ID: 1356897 [TBL] [Abstract][Full Text] [Related]
75. [The use of Béres Drops Plus, a preparation of trace and macroelements, in the combined therapy of gastric and duodenal peptic ulcer]. Shishkina TI; Zakharash MP Lik Sprava; 1997; (4):86-9. PubMed ID: 9471385 [TBL] [Abstract][Full Text] [Related]
76. Medical and surgical treatment of chronic gastric ulcer. Kelly KA; Malagelada JR Clin Gastroenterol; 1984 May; 13(2):621-34. PubMed ID: 6146418 [No Abstract] [Full Text] [Related]
77. [Action of histamine H2 receptor blockaders on gastric motor function in duodenal peptic ulcer]. Shcherbak VV; Glubochenko VG; Zaĭdman VE Klin Med (Mosk); 1984 Jun; 62(6):94-6. PubMed ID: 6147438 [No Abstract] [Full Text] [Related]
79. Formulary designation of cimetidine as the primary intravenous histamine H2-receptor antagonist. Berkowitz HS Am J Hosp Pharm; 1992 Jan; 49(1):134-5. PubMed ID: 1349201 [No Abstract] [Full Text] [Related]
80. [Effectiveness and tolerance of selected Polish antacids in the therapy of duodenal ulcer disease. A placebo- and ranitidine-controlled study]. Mach T Pol Tyg Lek; 1995; 50(1-35):797-800. PubMed ID: 11785199 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]